The contract seeks to acquire FDA-approved infectious disease and oncology assays formulated as single-use test cartridges and reagents compatible with the VA’s existing instrument or analyzer. Required assays include targets for C. difficile, SARS-CoV-2 with Influenza A/B and RSV, Strep A, MTB with Rif, a multiplex vaginal panel, GI panel, MRSA Carba-R, Norovirus, BCR-ABL, FII & FV, and vanA PCR. Kits must be storable at 2–28°C and require no refrigeration. Delivery timing will be determined by the PSHCS Microbiology Department.